Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Rxsight Inc

RXST ✗ NOT COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Medical Equipment, Supplies & Distribution ·

USA Micro Cap Analyst: HOLD

Last Close

$6.89

▼ -1.71%

Market Cap $286.58M · Vol 221.25K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$286.58M

Micro Cap

Div Yield

N/A

EPS Growth

-22.16%

YoY

RSI (14)

76.82

Momentum

Beta

1.16

vs Market

52W High

$13.22

47.88% below

52W Low

$4.49

53.45% above

Volume

221.25K

Avg 369.85K

P/B

1.56

Price-to-book

ROE

-13.99%

Return on equity

Free Float

92.91%

Public shares

Shariah Compliance8 STANDARDS

✗ Rxsight Inc (RXST) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does RXST pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+10.06%

+40.04%

+22.38%

-14.30%

YTD

-33.88%

-16.18%

-77.44%

-44.12%

Financials & Valuation

TTM · Annual

Total Revenue	$134.48M
Net Income	$-38,944,000.00
Revenue Growth (YoY)	+0.31%
Gross Margin	76.60%
Operating Margin	-35.84%
Net Profit Margin	-28.96%
ROE	-13.99%
ROA · ROIC	-12.33% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	3.17
P/B	1.56
P/FCF	N/A
EPS Growth	-22.16%
Outstanding Shares	41.59M

Technical Indicators

50-Day SMA	$5.50
200-Day SMA	$7.75
RSI (14)	76.82
Beta	1.16
52-Week High	$13.22
52-Week Low	$4.49

Volume Today	221.25K
Avg Daily Volume (30D)	369.85K
Relative Volume	0.60x
Volatility (10D)	49.39
Volatility (30D)	60.28
Free Float	92.91%

Analyst Consensus

HOLD

Current Price $6.89

Mean Target $8.04

52W Low$4.49 52W High$13.22

Current

Target

$4.49 $13.22

Current Analyst target

+16.73% upside potential · 10 analysts

Identifiers

ExchangeNasdaq

FIGIBBG00THX1YQ1

ISINUS78349D1072

CountryUnited States of America

Sub-IndustryMedical Equipment, Supplies & Distribution (NEC)

Earnings DateNov 6, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

ABT Abbott Laboratories -0.02% MDT Medtronic PLC +0.76% COR Cencora Inc +1.23% 7741.T Hoya Corp +0.32% BDX Becton Dickinson and Co +0.79%

Company Profile

RxSight, Inc. is a commercial-stage medical technology company engaged in providing customized vision to patients following cataract surgery. Its RxSight Light Adjustable Lens system (RxSight system) is a cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system is composed of RxSight Light Adjustable Lens (LAL), RxSight Light Delivery Device (LDD) and related accessories. The LAL is an intraocular lens (IOL) made from the silicone-based photosensitive material that undergoes controlled changes in refractive power when exposed to specific ultraviolet (UV) light patterns generated by the LDD. Its LAL uses a silicone formulation that enables changing the mechanical and optical properties of the lens following implantation. The LDD uses software and algorithms to deliver a short UV light exposure treatment that polymerizes specific portions of the lens and allows doctors to adjust spherical and cylindrical refraction.